K-number	K153481
Device name	0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe
Applicant	Becton, Dickinson and Company
Product code	NGT
Device class	Class II
Decision date	Apr 4, 2016
Decision	Substantially Equivalent
Regulation	880.5200

AI Summary

AI extraction for this record is queued and will appear within 24 hours. View full FDA record →

Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?

Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.

Start free trial →

Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →

0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe

Everything you need for a 510(k) submission. Nothing you don't.